Your browser doesn't support javascript.
Messenger RNA vaccines against SARS-CoV-2.
Topol, Eric J.
  • Topol EJ; Scripps Research, La Jolla, CA, USA. Electronic address: etopol@scripps.edu.
Cell ; 184(6): 1401, 2021 03 18.
Article in English | MEDLINE | ID: covidwho-1030852
ABSTRACT
The first two vaccines proven to be effective for inhibiting COVID-19 illness were both mRNA, achieving 95% efficacy (and safety) among 74,000 participants (half receiving placebo) after intramuscular delivery of two shots, 3-4 weeks apart. To view this Bench to Bedside, open or download the PDF.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: Vaccines, Synthetic / COVID-19 Vaccines / SARS-CoV-2 / COVID-19 Type of study: Prognostic study / Randomized controlled trials Topics: Vaccines Limits: Humans Language: English Journal: Cell Year: 2021 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Vaccines, Synthetic / COVID-19 Vaccines / SARS-CoV-2 / COVID-19 Type of study: Prognostic study / Randomized controlled trials Topics: Vaccines Limits: Humans Language: English Journal: Cell Year: 2021 Document Type: Article